ProShares Ultra Nasdaq Biotechnology
Registrant
ProShares Trust
Class ticker
Net Assets
$73,651,927
Holdings
231
Latest Report
May 31, 2026
Net Assets Over Time
Holdings · 231
Export CSV
Only this fund's positions in US-listed stocks Equibles tracks are shown. Other
holdings — bonds, foreign securities, and cash — aren't listed yet, so the positions
below are a fraction of the fund's
$73,651,927 in net assets.
Showing 1–50
of 231 holdings by value
· page 1 of 5
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | GILD | 25,542 | $3,433,611 | 4.66% | Long | EC | |
| Vertex Pharmaceuticals, Inc. | VRTX | 7,657 | $3,426,814 | 4.65% | Long | EC | |
| Amgen, Inc. | AMGN | 9,803 | $3,301,552 | 4.48% | Long | EC | |
| Regeneron Pharmaceuticals, Inc. | REGN | 3,840 | $2,360,755 | 3.21% | Long | EC | |
| Alnylam Pharmaceuticals, Inc. | ALNY | 4,904 | $1,480,910 | 2.01% | Long | EC | |
| Revolution Medicines, Inc. | RVMD | 7,326 | $1,153,698 | 1.57% | Long | EC | |
| Biogen, Inc. | BIIB | 5,425 | $1,063,300 | 1.44% | Long | EC | |
| Illumina, Inc. | ILMN | 5,653 | $921,213 | 1.25% | Long | EC | |
| United Therapeutics Corp. | UTHR | 1,620 | $902,048 | 1.22% | Long | EC | |
| Argenx SE | ARGX | 1,050 | $877,790 | 1.19% | Long | EC | |
| Insmed, Inc. | INSM | 7,968 | $851,859 | 1.16% | Long | EC | |
| Incyte Corp. | INCY | 7,359 | $711,910 | 0.97% | Long | EC | |
| Viatris, Inc. | VTRS | 42,565 | $692,107 | 0.94% | Long | EC | |
| Moderna, Inc. | MRNA | 14,600 | $688,974 | 0.94% | Long | EC | |
| Guardant Health, Inc. | GH | 4,850 | $628,997 | 0.85% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 3,712 | $587,610 | 0.80% | Long | EC | |
| Summit Therapeutics, Inc. | SMMT | 28,664 | $502,767 | 0.68% | Long | EC | |
| Exelixis, Inc. | EXEL | 9,600 | $484,608 | 0.66% | Long | EC | |
| Bridgebio Pharma, Inc. | BBIO | 7,167 | $474,885 | 0.64% | Long | EC | |
| Medpace Holdings, Inc. | MEDP | 1,051 | $469,913 | 0.64% | Long | EC | |
| Ionis Pharmaceuticals, Inc. | IONS | 6,109 | $467,339 | 0.63% | Long | EC | |
| Axsome Therapeutics, Inc. | AXSM | 1,890 | $443,167 | 0.60% | Long | EC | |
| Madrigal Pharmaceuticals, Inc. | MDGL | 847 | $421,188 | 0.57% | Long | EC | |
| BioMarin Pharmaceutical, Inc. | BMRN | 7,110 | $407,332 | 0.55% | Long | EC | |
| BioNTech SE | BNTX | 4,213 | $404,237 | 0.55% | Long | EC | |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 5,178 | $403,418 | 0.55% | Long | EC | |
| Sanofi SA | SNY | 9,047 | $395,082 | 0.54% | Long | EC | |
| Praxis Precision Medicines, Inc. | PRAX | 1,029 | $360,119 | 0.49% | Long | EC | |
| Cytokinetics, Inc. | CYTK | 4,553 | $349,488 | 0.47% | Long | EC | |
| BeOne Medicines Ltd. | ONC | 1,181 | $340,034 | 0.46% | Long | EC | |
| Krystal Biotech, Inc. | KRYS | 1,080 | $333,752 | 0.45% | Long | EC | |
| Tempus AI, Inc. | TEM | 6,424 | $324,219 | 0.44% | Long | EC | |
| Abivax SA | ABVX | 2,271 | $301,203 | 0.41% | Long | EC | |
|
Nuvalent, Inc.
|
670703107 | 2,705 | $298,605 | 0.41% | Long | EC | |
| Halozyme Therapeutics, Inc. | HALO | 4,364 | $290,381 | 0.39% | Long | EC | |
| ImmunityBio, Inc. | IBRX | 38,008 | $285,820 | 0.39% | Long | EC | |
| Vaxcyte, Inc. | PCVX | 5,321 | $273,499 | 0.37% | Long | EC | |
| Immunovant, Inc. | IMVT | 7,523 | $250,516 | 0.34% | Long | EC | |
| Kymera Therapeutics, Inc. | KYMR | 3,017 | $245,644 | 0.33% | Long | EC | |
| Protagonist Therapeutics, Inc. | PTGX | 2,361 | $235,061 | 0.32% | Long | EC | |
| Mirum Pharmaceuticals, Inc. | MIRM | 2,231 | $226,447 | 0.31% | Long | EC | |
| PTC Therapeutics, Inc. | PTCT | 3,062 | $226,129 | 0.31% | Long | EC | |
| Rhythm Pharmaceuticals, Inc. | RYTM | 2,526 | $223,096 | 0.30% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 2,905 | $213,518 | 0.29% | Long | EC | |
| Cogent Biosciences, Inc. | COGT | 6,002 | $209,830 | 0.28% | Long | EC | |
| CG oncology, Inc. | CGON | 3,123 | $194,532 | 0.26% | Long | EC | |
| Scholar Rock Holding Corp. | SRRK | 3,773 | $186,009 | 0.25% | Long | EC | |
| Centessa Pharmaceuticals plc | CNTA | 4,423 | $175,858 | 0.24% | Long | EC | |
| Caris Life Sciences, Inc. | CAI | 10,431 | $174,406 | 0.24% | Long | EC | |
| Ligand Pharmaceuticals, Inc. | LGND | 736 | $170,723 | 0.23% | Long | EC |